首页> 外文期刊>Arquivos de Gastroenterologia >PROGRESSION OF LIVER FIBROSIS IN MONOINFECTED PATIENTS BY HEPATITIS C VIRUS AND COINFECTED BY HCV AND HUMAN IMMUNODEFICIENCY VIRUS
【24h】

PROGRESSION OF LIVER FIBROSIS IN MONOINFECTED PATIENTS BY HEPATITIS C VIRUS AND COINFECTED BY HCV AND HUMAN IMMUNODEFICIENCY VIRUS

机译:丙型肝炎病毒单株感染患者肝纤维化进展及丙肝病毒和人免疫缺陷病毒共感染肝纤维化进展

获取原文
           

摘要

ContextThe progression of liver fibrosis in patients coinfected by hepatitis C virus and human immunodeficiency virus (HCV/HIV) has been increasingly studied in the past decade. Studies made before the highly active antiretroviral therapy suggest that HIV can change the natural history of the HCV infection, leading to a faster progression of the liver fibrosis.ObjectiveTo evaluate and compare the fibrosis progression in two groups of patients (HCV/HIV coinfected and HCV monoinfected)MethodsSeventy patients HCV monoinfected and 26 patients HCV/HIV coinfected who had not undertaken HCV treatment and were submitted to serial percutaneous liver biopsies were retrospectively evaluated. There was no difference in the fibrosis progression between the two groups.ConclusionThe fibrosis grade evolution was not worse in the coinfected patients. The immunosuppression absence and the shortest time period between the biopsies in the coinfected group are possible explanations.
机译:在过去的十年中,越来越多地研究了由丙型肝炎病毒和人类免疫缺陷病毒(HCV / HIV)共同感染的患者的肝纤维化进程。高活性抗逆转录病毒疗法之前的研究表明,HIV可以改变HCV感染的自然史,从而导致肝纤维化进程加快。目的评估和比较两组患者(HCV / HIV合并感染和HCV)的纤维化进展方法回顾性评估未接受HCV治疗并接受连续经皮肝活检的70例HCV单一感染患者和26例HCV / HIV合并感染患者。两组之间的纤维化进展无差异。结论在合并感染的患者中,纤维化程度的演变并不差。合并感染组中活检之间缺乏免疫抑制和最短时间间隔可能是解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号